Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Cyclically Adjusted Book per Share: $0.60 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:T14 Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd SGX:T14
73 GF Score
Price $2.65
GF Value $1.64
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted Book per Share?

Tianjin Pharmaceutical Da Ren Tang Group SGX:T14 -1.85% 73 Cyclically Adjusted Book per Share is $0.60 as of Jun. 2026. GuruFocus rates SGX:T14 with a GF Score™ of 73/100 and a GF Value™ of $1.64 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Tianjin Pharmaceutical Da Ren Tang Group's adjusted book value per share for the three months ended in Jun. 2026 was $1.139. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.60 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group's average Cyclically Adjusted Book Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Tianjin Pharmaceutical Da Ren Tang Group was 13.50% per year. The lowest was 5.60% per year. And the median was 9.50% per year.

As of today (2026-08-16), Tianjin Pharmaceutical Da Ren Tang Group's current stock price is $2.65. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $0.60. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio of today is 4.42.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tianjin Pharmaceutical Da Ren Tang Group was 8.51. The lowest was 2.55. And the median was 4.50.


Tianjin Pharmaceutical Da Ren Tang Group  (SGX:T14) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.65/0.60
=4.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tianjin Pharmaceutical Da Ren Tang Group was 8.51. The lowest was 2.55. And the median was 4.50.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted Book per Share Related Terms


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted Book per Share Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.25 0.42 0.51 0.59

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.52 0.59 0.63 0.60

SGX:T14 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio falls into.


SGX:T14
73GF Score
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd SGX:T14
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tianjin Pharmaceutical Da Ren Tang Group's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.139/116.0564*116.0564
=1.139

Current CPI (Jun. 2026) = 116.0564.

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.808 102.400 0.916
201612 0.786 102.600 0.889
201703 0.807 103.200 0.908
201706 0.821 103.100 0.924
201709 0.867 104.100 0.967
201712 0.891 104.500 0.990
201803 0.954 105.300 1.051
201806 0.930 104.900 1.029
201809 0.893 106.600 0.972
201812 0.931 106.500 1.015
201903 0.993 107.700 1.070
201906 0.963 107.700 1.038
201909 0.951 109.800 1.005
201912 0.999 111.200 1.043
202003 1.024 112.300 1.058
202006 1.002 110.400 1.053
202009 1.070 111.700 1.112
202012 1.148 111.500 1.195
202103 1.196 112.662 1.232
202106 1.216 111.769 1.263
202109 1.249 112.215 1.292
202112 1.292 113.108 1.326
202203 1.338 114.335 1.358
202206 1.246 114.558 1.262
202209 1.235 115.339 1.243
202212 1.209 115.116 1.219
202303 1.301 115.116 1.312
202306 1.148 114.558 1.163
202309 1.151 115.339 1.158
202312 1.200 114.781 1.213
202403 1.260 115.227 1.269
202406 1.123 114.781 1.135
202409 1.178 115.785 1.181
202412 1.399 114.893 1.413
202503 1.472 115.116 1.484
202506 1.589 114.907 1.605
202509 1.642 115.471 1.650
202512 1.309 115.832 1.312
202603 1.417 116.303 1.414
202606 1.139 116.056 1.139

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.60 mean?
Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) has a Cyclically Adjusted Book per Share of $0.60 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors.
Is Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Book per Share too high?
Tianjin Pharmaceutical Da Ren Tang Group's current Cyclically Adjusted Book per Share is $0.60. Overall, Tianjin Pharmaceutical Da Ren Tang Group has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Book per Share compare to ZTS?
Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Book per Share of $0.60 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors. Tianjin Pharmaceutical Da Ren Tang Group's current Cyclically Adjusted Book per Share is $0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Pharmaceutical Da Ren Tang Group stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.64, compared to a current price of $2.65 — trading 61.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is $0.60. Tianjin Pharmaceutical Da Ren Tang Group's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14), the current Cyclically Adjusted Book per Share is $0.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group stock appears to be overvalued. The current stock price of $2.65 is trading 61.6% above its estimated GF Value™ of $1.64. GuruFocus considers Tianjin Pharmaceutical Da Ren Tang Group to be Significantly Overvalued.

Key valuation signals for SGX:T14:

  • Cyclically Adjusted Book per Share: $0.60
  • GF Value™: $1.64 vs. price of $2.65 (61.6% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the SGX:T14 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tianjin Pharmaceutical Da Ren Tang Group Business Description

Other Exchanges 2TZ:Germany600329:China
Address No. 17 Baidi Road, Darentang Building, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company is engaged in the production and sale of traditional Chinese medicine, Western medicine, healthcare products, and investment holding. It operates in two segments, namely the Chinese Medicine segment and the Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures Western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese medicine.
73GF Score

Get the complete analysis for SGX:T14

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.65
Price
$1.64
GF Value